Correlation between promoter methylation of p14 ARF, TMS1/ASC, and DAPK, and p53 mutation with prognosis in cholangiocarcinoma

World Journal of Surgical Oncology

Volumn 10, Issue , 2012, Pages

  Xiaofang, Liu ^a   Kun, Tang ^a   Shaoping, Yu ^a   Zaiqiu, Wang ^a   Hailong, Su ^a  

^a QINGDAO UNIVERSITY MEDICAL COLLEGE   (China)

Author keywords

Cholangiocarcinoma; Methylation specific pcr; P53 bax mitochondrial apoptosis pathway

Indexed keywords

CYCLIN DEPENDENT KINASE INHIBITOR 2A; DEATH ASSOCIATED PROTEIN KINASE; PROTEIN P53; APOPTOSIS REGULATORY PROTEIN; CALCIUM CALMODULIN DEPENDENT PROTEIN KINASE; CYTOSKELETON PROTEIN; DEATH-ASSOCIATED PROTEIN KINASE; DNA; PYCARD PROTEIN, HUMAN; TP53 PROTEIN, HUMAN; TUMOR MARKER;

ARTICLE; BILE DUCT CARCINOMA; CANCER INVASION; CANCER PATIENT; CANCER PROGNOSIS; CLINICAL ASSESSMENT; CONTROLLED STUDY; CPG ISLAND; DNA METHYLATION; EXON; GENE MUTATION; GENE SEQUENCE; GENETIC ASSOCIATION; GENETIC CORRELATION; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; LYMPH NODE METASTASIS; POLYMERASE CHAIN REACTION; PROMOTER REGION; SIGNAL TRANSDUCTION; SURVIVAL RATE; TUMOR DIFFERENTIATION; TUMOR SUPPRESSOR GENE; ADULT; AGED; BILE DUCT TUMOR; CANCER STAGING; FEMALE; GENE EXPRESSION REGULATION; GENETICS; INTRAHEPATIC BILE DUCT; MALE; MIDDLE AGED; MORTALITY; MUTATION; PATHOLOGY; PROGNOSIS;

ADULT; AGED; APOPTOSIS REGULATORY PROTEINS; BILE DUCT NEOPLASMS; BILE DUCTS, INTRAHEPATIC; CALCIUM-CALMODULIN-DEPENDENT PROTEIN KINASES; CHOLANGIOCARCINOMA; CYTOSKELETAL PROTEINS; DNA METHYLATION; DNA, NEOPLASM; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MALE; MIDDLE AGED; MUTATION; NEOPLASM STAGING; POLYMERASE CHAIN REACTION; PROGNOSIS; PROMOTER REGIONS, GENETIC; SURVIVAL RATE; TUMOR MARKERS, BIOLOGICAL; TUMOR SUPPRESSOR PROTEIN P14ARF; TUMOR SUPPRESSOR PROTEIN P53;

EID: 84857139080     PISSN: None     EISSN: 14777819     Source Type: Journal    
DOI: 10.1186/1477-7819-10-5     Document Type: Article

References (16)

1. Schuler M, Green DR. Mechanisms of p53-dependent apoptosis. Biochemical Society Transactions 2001, 29(6):684-688. 10.1042/BST0290684, 11709054.
2. Jones PA. Death and methylation. Nature 2001, 409:141-143.
3. Liu XF, Zhu SG, Zhang H. The methylation status of the TMS1/ASC gene in cholangiocarcinoma and its clinical significance. HBPT INT 2006, (5):449-453.
4. Liu XF, Zhang H, Zhu SG. Corrlation of p53 gene mutation and expression in cholangiocarcinoma. World J Gastroenterology 2006, (12):4609-4772.
5. Mosconi S, Beretta GD, Labianca R, Zampino MG, Gatta G, Heinemann V. Cholangiocarcinoma. Crit Rev Oncol Hematol 2009, 69:259-270. 10.1016/j.critrevonc.2008.09.008, 18977670.
6. Khan SA, Thomas HC, Davidson BR, Taylor-Robinson SD. Cholangiocarcino -ma. Lancet 2005, 366:1303-1314. 10.1016/S0140-6736(05)67530-7, 16214602.
7. Paik WH, Park YS, Hwang JH, Lee SH, Yoon CJ, Kang SG. Palliative treatment with self-expandable metallic stents in patients with advanced type III or IV hilar cholangiocarcinoma: a percutaneous versus endoscopic approach. Gastrointest Endosc 2009, 69:55-62. 10.1016/j.gie.2008.04.005, 18657806.
8. Aljiffry M, Walsh MJ, Molinari M. Advances in diagnosis, treatment and palliation of cholangiocarcinoma: 1990-2009. World J Gastroenterol 2009, 15:4240-4262. 10.3748/wjg.15.4240, 2744180, 19750567.
9. Shaib YH, El-Serag HB, Nooka AK, Thomas M, Brown TD, Patt YZ, Hassan MM. Risk factors for intrahepatic and extrahepatic cholangiocarcinoma: a hospital-based case-control study. Am J Gastroenterol 2007, 102:1016-1021. 10.1111/j.1572-0241.2007.01104.x, 17324130.
10. Welzel TM, Graubard BI, El-Serag HB, Shaib YH, Hsing AW, Davila JA, McGlynn KA. Risk factors for intrahepatic and extrahepatic cholangiocarcinoma in the United States: a population-based case-control study. Clin Gastroenterol Hepatol 2007, 5:1221-1228. 10.1016/j.cgh.2007.05.020, 2083573, 17689296.
11. Shaib Y, El-serav HB. The epidemiology of cholangiocarcinoma. Sem in Liver Dis 2004, 24:115-125.
12. Fraga MF, Uriol E, Diego LB. High performance capillary electrophoretic method for the quantification of 5-methyl-2'-deoxycytidine in genomic DNA:application to plant, animal and human cancer tissues. Electrophoresis 2002, (23):1677-1681.
13. Baylin SB, Esteller M, Rountree MR. Aberrant patterns of DNA methylation, chromation and gene expression in cancer. Hum Mol Genet 2001, (10):687-692.
14. Ohtsuka T, Ryu H, Minamishima YA, Macip S. ASC is a Bax adaptor and regulates the p53-Bax mitochondrial apoptosis pathway. Nature Cell Biology 2004, 6(2):121-128. 10.1038/ncb1087, 14730312.
15. Ohtsuka T, Liu XF, Koga Y. Methylation-induced silencing of ASC and the effect of expressed ASC on p53-mediated chemosensitivity in colorectal cancer. Oncogene 2006, (25):1807-1811.
16. Yuasa Y. DNA methylation in cancer and aging. Mechanisms of aging and development 2002, 123:1649-1654.